
GUJARAT KIDNEY N SUP SP L Q2 Results FY27: PAT Jumps 129.17% to Rs 6.60 Cr, Revenue Rs 38.09 Cr
Updated: 4 Nov 2026 • 7:15 pm
Posted by:

Quick Answer
GUJARAT KIDNEY N SUP SP L Q2 Results FY27 were declared on 4 November 2026, and the quarterly results show consolidated revenue of Rs 38.09 Cr, up 194.59% YoY from Rs 12.93 Cr. Net profit more than doubled to Rs 6.60 Cr from Rs 2.88 Cr, a YoY growth of 129.17%, while Operating Profit reached Rs 10.22 Cr. The figures cover the July to September 2026 quarter on a Consolidated basis.
GUJARAT KIDNEY N SUP SP L (GKSL) Q2 Results FY27 announced on 4 November 2026, covering the company's financial performance for the July to September quarter. GUJARAT KIDNEY N SUP SP L Q2 Results FY27 show much higher revenue, Operating Profit and net profit than the year-earlier quarter. The results date filing reports consolidated results with revenue of Rs 38.09 Cr and PAT of Rs 6.60 Cr on the NSE and BSE.
This results analysis of GUJARAT KIDNEY N SUP SP L Q2 Results covers the financial highlights, business drivers, outlook and risks for the quarter. Univest readers can go straight to the Financial Highlights table below, which sets the latest figures against the same quarter a year before.
Click Here – Get Free Investment Predictions
GUJARAT KIDNEY N SUP SP L Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 38.09 Cr | Rs 12.93 Cr | +194.59% YoY |
| Operating Profit | Rs 10.22 Cr | Rs 5.12 Cr | +99.61% YoY |
| Net Profit (PAT) | Rs 6.6 Cr | Rs 2.88 Cr | +129.17% YoY |
Source: company filing for GUJARAT KIDNEY N SUP SP L Q2 Results FY27, 4 November 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from GUJARAT KIDNEY N SUP SP L Q2 Results: What Stands Out
- Revenue of Rs 38.09 Cr grew 194.59% YoY from Rs 12.93 Cr, an addition of Rs 25.16 Cr in the consolidated results.
- Net profit of Rs 6.60 Cr rose 129.17% YoY from Rs 2.88 Cr, a slower rate than the growth in revenue.
- Operating Profit of Rs 10.22 Cr increased 99.61% YoY from Rs 5.12 Cr, roughly double the year-earlier level.
- Revenue has risen in each of the last 4 quarters, while return on capital employed was 15.51% in FY26.
- GUJARAT KIDNEY N SUP SP L Q2 Results FY27 also show a narrower net profit margin of 17.3%, which the performance analysis addresses next.
GUJARAT KIDNEY N SUP SP L Q2 Results FY27: Performance Analysis
GUJARAT KIDNEY N SUP SP L Q2 Results FY27 show consolidated revenue of Rs 38.09 Cr, Operating Profit of Rs 10.22 Cr and net profit of Rs 6.60 Cr, all above the year-earlier quarter. Revenue rose 194.59% YoY, Operating Profit 99.61% and net profit 129.17%.
The results analysis shows net profit adding Rs 3.72 Cr YoY, against Rs 25.16 Cr more revenue and Rs 5.10 Cr more Operating Profit. Net profit equals 17.33% of revenue in the latest quarter, compared with 22.27% a year earlier, a ratio drawn only from the reported figures.
Net profit margin narrowed to 17.3% from 22.3% because revenue grew faster than net profit. Investors tracking GUJARAT KIDNEY N SUP SP L Q2 Results can read these quarterly results with that margin movement in view, which is where the results analysis turns to the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue Growth YoY – The results analysis begins with revenue, which grew 194.6% year on year to Rs 38.09 Cr in the latest quarter. Both the Operating Profit and the net profit in the consolidated results are reported on this much larger top line.
Net Profit Growth YoY – Net profit rose 129.2% year on year to Rs 6.60 Cr from Rs 2.88 Cr. GUJARAT KIDNEY N SUP SP L Q2 Results FY27 therefore show profit more than doubling, with Operating Profit of Rs 10.22 Cr reported alongside.
Consecutive Revenue Rises and Return on Capital Employed – Revenue has risen in each of the last 4 quarters, and return on capital employed was 15.51% in FY26. These quarterly results sit within that record, although the supplied figures do not establish the specific cause.
FY27 Outlook After GUJARAT KIDNEY N SUP SP L Q2 Results
Full-year FY27 results will depend on the quarters still to be reported and on disclosed sector conditions, so this results analysis does not project them. The latest quarter supplies net profit of Rs 6.60 Cr and revenue of Rs 38.09 Cr as the figures against which later filings will be compared.
GUJARAT KIDNEY N SUP SP L Q2 Results FY27 extend a four-quarter run of rising revenue, and the next consolidated results will show whether that run continues. Readers following net profit should keep the margin and return ratios in view, which leads directly to the risks.
Key Risks to Watch After GUJARAT KIDNEY N SUP SP L Q2 Results FY27
Narrower Net Profit Margin
Net profit margin narrowed to 17.3% from 22.3% in the comparison quarter. Even after GUJARAT KIDNEY N SUP SP L Q2 Results FY27 recorded strong YoY growth in profit, this movement shows profit growing more slowly than revenue.
Volatile Quarterly Net Profit
Quarterly net profit has been volatile, ranging from Rs 2.88 Cr to Rs 6.60 Cr over the last 5 quarters. The latest quarter is the highest of that range, so later filings may show a different level.
Return on Equity Decline
Return on equity declined to 12.08% in FY26 from 68.65% in FY25. This annual measure sits apart from the quarterly numbers, and investors can follow it in later filings alongside the YoY growth in revenue.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
GUJARAT KIDNEY N SUP SP L Q2 Results FY27 report consolidated revenue of Rs 38.09 Cr, Operating Profit of Rs 10.22 Cr and net profit of Rs 6.60 Cr, each higher YoY. Readers of GUJARAT KIDNEY N SUP SP L Q2 Results should treat these quarterly results as one filing and compare them only with other consolidated results. Investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on GUJARAT KIDNEY N SUP SP L Q2 Results FY27
What are GUJARAT KIDNEY N SUP SP L Q2 Results FY27?
Ans. GUJARAT KIDNEY N SUP SP L Q2 Results FY27 are the consolidated quarterly results for July to September 2026, with revenue of Rs 38.09 Cr and net profit of Rs 6.60 Cr, as the Quick Answer box above explains.
What is the results date for GUJARAT KIDNEY N SUP SP L Q2 Results FY27?
Ans. The results date for GUJARAT KIDNEY N SUP SP L Q2 Results FY27 was 4 November 2026, so the quarterly results cover July to September 2026, as the opening paragraphs of this article state.
What revenue was reported in GUJARAT KIDNEY N SUP SP L Q2 Results FY27?
Ans. GUJARAT KIDNEY N SUP SP L reported consolidated revenue of Rs 38.09 Cr in the quarter against Rs 12.93 Cr a year earlier, as the Financial Highlights table shows next to the percentage change.
What net profit was reported in GUJARAT KIDNEY N SUP SP L Q2 Results FY27?
Ans. Net profit was Rs 6.60 Cr in the quarter, compared with Rs 2.88 Cr in the same quarter last year, so the Key Takeaways section records a rise of 129.17%.
How much YoY growth did revenue show in GUJARAT KIDNEY N SUP SP L Q2 Results FY27?
Ans. Revenue showed YoY growth of 194.59% in the quarter, moving from Rs 12.93 Cr to Rs 38.09 Cr, while the Performance Analysis section puts the absolute rise at Rs 25.16 Cr.
Did net profit rise or fall in GUJARAT KIDNEY N SUP SP L Q2 Results?
Ans. GUJARAT KIDNEY N SUP SP L Q2 Results show net profit rising from Rs 2.88 Cr to Rs 6.60 Cr, a 129.17% increase, so the results analysis in the Performance Analysis section places profit growth below revenue growth.
What was the Operating Profit in GUJARAT KIDNEY N SUP SP L Q2 Results FY27?
Ans. Operating Profit in GUJARAT KIDNEY N SUP SP L Q2 Results FY27 was Rs 10.22 Cr against Rs 5.12 Cr a year earlier, a rise of 99.61%, as the Key Takeaways section notes alongside revenue and net profit.
Are GUJARAT KIDNEY N SUP SP L Q2 Results consolidated results or standalone results?
Ans. GUJARAT KIDNEY N SUP SP L Q2 Results are consolidated results, not standalone results, so the revenue, Operating Profit and net profit figures should be compared only with other consolidated results, as the opening paragraphs state.
What business factors shaped GUJARAT KIDNEY N SUP SP L Q2 Results FY27?
Ans. GUJARAT KIDNEY N SUP SP L Q2 Results FY27 were shaped by 194.6% YoY revenue growth, a 129.2% rise in net profit and four straight quarters of rising revenue, as detailed under Key Business Factors.
What are the key risks after GUJARAT KIDNEY N SUP SP L Q2 Results FY27?
Ans. The risks after GUJARAT KIDNEY N SUP SP L Q2 Results FY27 are a narrower net profit margin, volatile quarterly net profit and a decline in return on equity in FY26, as the Key Risks section details.
What is the outlook after GUJARAT KIDNEY N SUP SP L Q2 Results?
Ans. Full-year outcomes after GUJARAT KIDNEY N SUP SP L Q2 Results depend on the quarters still to be reported, so the FY27 Outlook section treats the current revenue and net profit as reference points rather than a forecast.
Where can I find the complete GUJARAT KIDNEY N SUP SP L Q2 Results FY27 data?
Ans. The complete data for GUJARAT KIDNEY N SUP SP L Q2 Results FY27 sits in the Financial Highlights table of this article, while readers can also look up GKSL on the Univest Screener and the Univest app.
Recent Articles

Dabur India Q2 Results FY27: Revenue Rises 11.65% YoY to Rs 3,563.07 Cr, PAT Rs 498.57 Cr
4 November 2026

Ruchi Infrastructure Q2 Results FY27: Net Profit Jumps 160.84% to Rs 3.73 Cr, Revenue Rs 16.53 Cr
4 November 2026

Vidya Wires Q2 Results FY27: Revenue Jumps 52.5% YoY to Rs 580.94 Cr, PAT Rs 14.86 Cr
4 November 2026

Navneet Education Q2 Results FY27: Net Loss Narrows to Rs 3 Cr, Revenue Rs 324 Cr, PAT Rs -3 Cr
4 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Dabur India Q2 Results FY27: Revenue Rises 11.65% YoY to Rs 3,563.07 Cr, PAT Rs 498.57 Cr
Ruchi Infrastructure Q2 Results FY27: Net Profit Jumps 160.84% to Rs 3.73 Cr, Revenue Rs 16.53 Cr
Vidya Wires Q2 Results FY27: Revenue Jumps 52.5% YoY to Rs 580.94 Cr, PAT Rs 14.86 Cr
Navneet Education Q2 Results FY27: Net Loss Narrows to Rs 3 Cr, Revenue Rs 324 Cr, PAT Rs -3 Cr
SANATHAN TEXTILES Q2 Results FY27: Net Profit Jumps 204.32% to Rs 61.23 Cr, Revenue Rs 1,803.97 Cr
Popular this week
SMS Pharmaceuticals Q2 Results FY27: Net Profit Jumps 57.45% to Rs 39.85 Cr, Revenue Rs 316.09 Cr

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





